In the long tradition of medicine's most consequential accidents, researchers at the Medical University of South Carolina discovered while studying kidney disease that formoterol — an asthma drug prescribed for decades — may reverse fatty liver disease by restoring the energy-producing capacity of damaged cells. The finding arrives at a moment when MASH, a progressive liver condition tied to obesity and diabetes, affects hundreds of millions worldwide and remains largely without effective treatment. Human trials are now underway, carrying the quiet possibility that a familiar, inexpensive drug
News-Medical
· May 09, 2026
· health
· 4 min read
Medium
Sourcing: Characterized
Asthma drug formoterol shows potential to reverse fatty liver disease in mice
MASH affects hundreds of millions worldwide and is a leading cause of liver transplantation and liver failure.
◉
Health & Medicine
7994 related articles
Dr. Reddy's Wins Semaglutide Approval as Novo Nordisk Patent Challenge…
NDTV Profit · 100% match
EU safety committee reviews reports of menstrual changes after mRNA CO…
CNBC · 99% match
Canada faces new COVID epidemic, not third wave, as variants target di…
The Globe and Mail · 99% match
Researchers identify new Ebola variant, propose repurposed drug treatm…
Medical Xpress · 99% match
Dalhousie researchers identify new Ebola variant, propose repurposed d…
Education News Canada · 99% match
Related Coverage
The Guardian · Aug 18
ADHD diagnosis surge raises questions about identity versus disorder
Experts warn that rising ADHD diagnoses increasingly reflect identity-seeking rather than medical need, with poor-qualit…
BBC News · Aug 18 BBC investigation expands: 30 children feared conceived with wrong donors at Cyprus IVF clinicsAt least 30 children, mostly British, are feared conceived via IVF in northern Cyprus using wrong sperm or egg donors th…
News-Medical · Aug 18 IV Iron Use Among Australian Women Surges 17-Fold in DecadeAustralian women's intravenous iron use jumped 17-fold in a decade, with 1 in 20 reproductive-age women receiving treatm…
geneonline.com · Aug 18 1 in 20 Australian Women Now Receiving IV Iron InfusionsOne in 20 Australian women now receive intravenous iron infusions, marking a significant decade-long increase in this tr…
Bias & Framing
No detailed analysis data available for this lens. Try re-running lenses from the admin panel.
Geopolitical Impact
🌎
Medical research discovery of asthma drug's potential liver disease treatment has no direct geopolitical implications; primarily a scientific/pharmaceutical development.
Escalation Risk
low
Confidence
HIGH
No immediate power dynamics shifts. Potential long-term pharmaceutical market competition if formoterol proves effective in human trials for MASH treatment.
Economic Lens
📈
Asthma drug formoterol shows potential to treat fatty liver disease (MASH) by improving mitochondrial function, with human trials underway, potentially creating a new therapeutic market and repurposing opportunity.
Market Signal
bullish
Confidence
MED
Pharmaceutical/Biotechnology
Healthcare/Medical Devices
Respiratory Medicine
Hepatology/Liver Disease Treatment
Clinical Research and Development
If confirmed in human trials, patients with MASH could access an affordable, existing medication rather than waiting for new treatments, reducing healthcare costs and improving outcomes for hundreds of millions affected by fatty liver disease globally.
FDA may expedite approval pathways for drug repurposing; healthcare systems may expand formoterol prescribing beyond respiratory conditions; insurance coverage policies may evolve to include hepatic indications; regulatory frameworks for off-label use may be clarified.